66 related articles for article (PubMed ID: 38704377)
21. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Lu J; Ding Y; Chen Y; Jiang J; Chen Y; Huang Y; Wu M; Li C; Kong M; Zhao W; Wang H; Zhang J; Li Z; Lu Y; Yu X; Jin K; Zhou D; Zhou T; Teng F; Zhang H; Zhou Z; Wang H; Teng L
Nat Commun; 2021 Jun; 12(1):3946. PubMed ID: 34168152
[TBL] [Abstract][Full Text] [Related]
22. Distinct genomic profile in h. pylori-associated gastric cancer.
Zhang X; Liu F; Bao H; Wang A; Han M; Wu X; Gu Y; Zheng L
Cancer Med; 2021 Apr; 10(7):2461-2469. PubMed ID: 33751865
[TBL] [Abstract][Full Text] [Related]
23. Current treatment and recent progress in gastric cancer.
Joshi SS; Badgwell BD
CA Cancer J Clin; 2021 May; 71(3):264-279. PubMed ID: 33592120
[TBL] [Abstract][Full Text] [Related]
24. Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer.
Zhu Z; Fu H; Wang S; Yu X; You Q; Shi M; Dai C; Wang G; Cha W; Wang W
Ann Transl Med; 2020 Nov; 8(22):1484. PubMed ID: 33313229
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
26. Gastric cancer.
Smyth EC; Nilsson M; Grabsch HI; van Grieken NC; Lordick F
Lancet; 2020 Aug; 396(10251):635-648. PubMed ID: 32861308
[TBL] [Abstract][Full Text] [Related]
27. Metastasectomy Improves the Survival of Gastric Cancer Patients with Krukenberg Tumors: A Retrospective Analysis of 182 patients.
Ma F; Li Y; Li W; Kang W; Liu H; Ma S; Xie Y; Zhong Y; Xu Q; Wang B; Xue L; Tian Y
Cancer Manag Res; 2019; 11():10573-10580. PubMed ID: 31908529
[TBL] [Abstract][Full Text] [Related]
28. Tumour evolution in hepatocellular carcinoma.
Craig AJ; von Felden J; Garcia-Lezana T; Sarcognato S; Villanueva A
Nat Rev Gastroenterol Hepatol; 2020 Mar; 17(3):139-152. PubMed ID: 31792430
[TBL] [Abstract][Full Text] [Related]
29. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
30. Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K; Kodera Y; Kochi M; Ichikawa W; Kakeji Y; Sano T; Nagao N; Takahashi M; Takagane A; Watanabe T; Kaji M; Okitsu H; Nomura T; Matsui T; Yoshikawa T; Matsuyama J; Yamada M; Ito S; Takeuchi M; Fujii M
J Clin Oncol; 2019 May; 37(15):1296-1304. PubMed ID: 30925125
[TBL] [Abstract][Full Text] [Related]
31. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.
Nakayama I; Shinozaki E; Sakata S; Yamamoto N; Fujisaki J; Muramatsu Y; Hirota T; Takeuchi K; Takahashi S; Yamaguchi K; Noda T
Cancer Sci; 2019 Apr; 110(4):1352-1363. PubMed ID: 30771244
[TBL] [Abstract][Full Text] [Related]
32. Frequent
Tanaka A; Ishikawa S; Ushiku T; Yamazawa S; Katoh H; Hayashi A; Kunita A; Fukayama M
Oncotarget; 2018 Jun; 9(50):29336-29350. PubMed ID: 30034621
[TBL] [Abstract][Full Text] [Related]
33. PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
Wang Q; Shi YL; Zhou K; Wang LL; Yan ZX; Liu YL; Xu LL; Zhao SW; Chu HL; Shi TT; Ma QH; Bi J
Cell Death Dis; 2018 Jul; 9(7):739. PubMed ID: 29970892
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
[TBL] [Abstract][Full Text] [Related]
35. Proposed Molecular and miRNA Classification of Gastric Cancer.
Alessandrini L; Manchi M; De Re V; Dolcetti R; Canzonieri V
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882766
[TBL] [Abstract][Full Text] [Related]
36. MutationalPatterns: comprehensive genome-wide analysis of mutational processes.
Blokzijl F; Janssen R; van Boxtel R; Cuppen E
Genome Med; 2018 Apr; 10(1):33. PubMed ID: 29695279
[TBL] [Abstract][Full Text] [Related]
37. Genetic insights into the morass of metastatic heterogeneity.
Hunter KW; Amin R; Deasy S; Ha NH; Wakefield L
Nat Rev Cancer; 2018 Apr; 18(4):211-223. PubMed ID: 29422598
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
Korourian A; Roudi R; Shariftabrizi A; Madjd Z
Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
[TBL] [Abstract][Full Text] [Related]
39. Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.
Singh P; Toom S; Huang Y
J Hematol Oncol; 2017 May; 10(1):105. PubMed ID: 28494772
[TBL] [Abstract][Full Text] [Related]
40. Reconstructing metastatic seeding patterns of human cancers.
Reiter JG; Makohon-Moore AP; Gerold JM; Bozic I; Chatterjee K; Iacobuzio-Donahue CA; Vogelstein B; Nowak MA
Nat Commun; 2017 Jan; 8():14114. PubMed ID: 28139641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
